Which is true about type II hypersensitivity reaction?
## Core Concept
Type II hypersensitivity reactions, also known as cytotoxic hypersensitivity reactions, involve the binding of antibodies to specific antigens on the surface of host cells, leading to cell damage or destruction. This process typically involves IgG and IgM antibodies. The reaction can occur through several mechanisms, including complement activation and antibody-dependent cellular cytotoxicity.
## Why the Correct Answer is Right
The correct answer involves understanding that type II hypersensitivity reactions are characterized by the direct interaction between antibodies and cell surface antigens, which can lead to cell lysis through complement activation or through immune effector cells. Examples include autoimmune hemolytic anemia, where antibodies target red blood cell antigens, and Goodpasture syndrome, where antibodies target the basement membrane of the lungs and kidneys.
## Why Each Wrong Option is Incorrect
- **Option A:** This option is incorrect because it does not accurately describe a characteristic of type II hypersensitivity reactions. Without the specific details of option A, we can infer that any option not describing direct antibody-antigen interaction leading to cell damage would be incorrect.
- **Option B:** Similarly, this option would be incorrect if it describes a mechanism or characteristic not specific to type II hypersensitivity reactions, such as involving T cell responses or immune complex deposition, which are more characteristic of type III or type IV hypersensitivity reactions.
- **Option C:** This option would also be incorrect if it does not align with the known mechanisms of type II hypersensitivity reactions.
## Clinical Pearl / High-Yield Fact
A key point to remember is that type II hypersensitivity reactions can be caused by both autoantibodies (antibodies against self-antigens) and isoantibodies (antibodies against non-self antigens from another individual of the same species). A classic example is hemolytic disease of the newborn, where maternal isoantibodies against fetal red blood cell antigens lead to hemolysis.
## Correct Answer: D.